Pharma News

In-Cosmetics Global 2026 Exhibition & Conference was held in Paris, France at the Paris Expo porte de versailles from 14th to 16th April 2026.

In a major development in the fight against obesity, Boehringer Ingelheim has announced encouraging results for its experimental drug survodutide, offering new hope for people struggling with overweight and obesity.

Boehringer Ingelheim India Private Limited and the National Institute of Pharmaceutical Education and Research (NIPER), Hajipur today signed a Memorandum of Understanding (MoU) to advance pharmaceutical research, education and innovation. The five-year collaboration will create new pathways for researchers and students in Bihar and the wider region to engage with global-standard open science platforms, joint research initiatives and capability-building programmes thus strengthening the talent pipeline for India’s next phase of pharmaceutical innovation.

Colorectal cancer is one of the most common types of cancer in the Western world and a leading cause of cancer-related deaths. Age, diet and lifestyle are known risk factors. However, in most cases we still lack a precise understanding of what triggers the disease.

In recent years, researchers have increasingly turned their attention to the ecosystem of the gut – the vast community of bacteria, viruses and other microorganisms that live there.

Hygiene in everyday items that touch the body—such as clothing, masks, and toothbrushes—is critically important. The underlying principle of how graphene selectively eliminates only bacteria has now been revealed. A KAIST research team has presented the potential for a next-generation antibacterial material that is safe for the human body and capable of replacing antibiotics.

In a move that has sent shockwaves across the global pharmaceutical industry, Sun Pharmaceutical Industries Limited has announced its biggest-ever acquisition, buying Organon & Co. in a massive USD 11.75 billion all-cash deal.
This isn’t just another corporate transaction. It’s a statement. A signal that Indian pharma is no longer playing catch-up, it’s ready to lead.

Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, successfully organized an insightful webinar entitled “Role of Artificial Intelligence in Pharmacy Careers & IT Impact”; jointly in collaboration with the Indian Pharmaceutical Association (IPA) - Hospital Pharmacy Division and RISE Trainings, Bengaluru. 

Cipla Limited and its wholly owned subsidiary Cipla USA Inc., announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol, 90 mcg per actuation from the United States Food and Drug Administration (USFDA). It is the first AB–rated generic therapeutic equivalent of Ventolin® HFA, marketed by GlaxoSmithKline.